Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.2500 (-0.68%) ($10.2500 - $10.2500) on Mon. Feb. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.12% (three month average) | RSI | 29 | Latest Price | $10.2500(-0.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.6% a day on average for past five trading days. | Weekly Trend | BCRX declines -1.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(37%) XBI(30%) IBB(27%) SDY(26%) IFRA(24%) | Factors Impacting BCRX price | BCRX will decline at least -1.56% in a week (0% probabilities). VIXM(-16%) UUP(-9%) VXX(-7%) TLT(-1%) SMH(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.56% (StdDev 3.12%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $10.47 | 5 Day Moving Average | $10.35(-0.97%) | 10 Day Moving Average | $10.45(-1.91%) | 20 Day Moving Average | $10.47(-2.1%) | To recent high | -25.6% | To recent low | 2.6% | Market Cap | $1.808b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |